Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

2.
3.

The neuregulin-I/ErbB signaling system in development and disease.

Britsch S.

Adv Anat Embryol Cell Biol. 2007;190:1-65. Review.

PMID:
17432114
4.

The role of erbB-2 and its ligands in growth control of malignant breast epithelium.

Lupu R, Dickson RB, Lippman ME.

Princess Takamatsu Symp. 1991;22:49-60. Review.

PMID:
1688228
5.

ErbB4 and its isoforms: patentable drug targets?

Paatero I, Elenius K.

Recent Pat DNA Gene Seq. 2008;2(1):27-33. Review.

PMID:
19075942
6.

Localization and modulation of ErbB receptor tyrosine kinases.

Carraway KL 3rd, Sweeney C.

Curr Opin Cell Biol. 2001 Apr;13(2):125-30. Review.

PMID:
11248544
7.

Structural requirements for ErbB2 transactivation.

Penuel E, Schaefer G, Akita RW, Sliwkowski MX.

Semin Oncol. 2001 Dec;28(6 Suppl 18):36-42. Review.

PMID:
11774204
8.

ErbB receptors: possible therapeutic targets in prostate cancer?

Ratan HL, Gescher A, Steward WP, Mellon JK.

BJU Int. 2003 Dec;92(9):890-5. Review. No abstract available.

9.

Function of ERBB4 is determined by alternative splicing.

Veikkolainen V, Vaparanta K, Halkilahti K, Iljin K, Sundvall M, Elenius K.

Cell Cycle. 2011 Aug 15;10(16):2647-57. Epub 2011 Aug 15. Review.

PMID:
21811097
10.

Dynamic equilibrium between multiple active and inactive conformations explains regulation and oncogenic mutations in ErbB receptors.

Landau M, Ben-Tal N.

Biochim Biophys Acta. 2008 Jan;1785(1):12-31. Epub 2007 Aug 22. Review.

PMID:
18031935

Supplemental Content

Support Center